Semaglutide linked to lower predicted dementia risk
Points and comments are a snapshot, not live.
Semaglutide linked to lower predicted dementia risk based on proteomics signature.
The study examines semaglutide's effect on a proteomics-based dementia risk signature, suggesting a potential link to reduced dementia risk. The article text is behind a CAPTCHA, so full details are unavailable.
What commenters are saying
Commenters find the results interesting, noting diabetes is a known dementia risk factor. Some discuss confounding factors like sedentary lifestyle and sugar-heavy diets. Others debate whether effects are from weight loss, appetite suppression, or anti-inflammatory mechanisms. A recent study linking semaglutide to a rare vision condition (NAION) is mentioned, with caveats about absolute risk being low (1 in 10,000 for diabetics).